Astathera - Crunchbase Company Profile & Funding

Q: Where is Astathera's headquarters?

Astathera is located in Ningbo, Zhejiang, China.

Q: Who invested in Astathera?

Astathera has 8 investors including Founder Duoce And Finnova Capital.

Q: When was the last funding round for Astathera?

Astathera closed its last funding round on obfuscated from a Series A round.

Overview

Astathera

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Astathera

CB Rank

286026

Astathera focuses on producing and developing medical nuclides and drugs, offering treatment solutions.

Founded

obfuscation

Private

Series A

Ningbo, Zhejiang, China

51-100

www.astathera.com

Biopharma

Medical

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Details

Legal Name

Trifa Nucla (Ningbo) Medical Technology Co., Ltd.

Also Known As

Trifa, Alphanuclear

Operating Status

Active

Company Type

For Profit

About the Company

Astathera focuses on producing and developing medical nuclides and drugs, offering treatment solutions that integrate disease diagnosis and treatment.

Phone Number

(0574)82353522

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Astatine-211 (At-211)

Astatine-211 is an alpha-particle emitting radionuclide used for targeted alpha therapy in cancer treatment.

Germanium-68 (Ge-68)

Germanium-68 is a radionuclide produced via cyclotron used as a parent isotope in generator systems for medical imaging isotopes.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Astathera	5	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Founder Duoce	—	Series A - Astathera	—
Founder Duoce	—	Series A - Astathera	—
Founder Duoce	—	Series A - Astathera	—
Founder Duoce	—	Series A - Astathera	—
Founder Duoce	—	Series A - Astathera	—